Latest news for Positron (OTC:POSC) Stock

Positron Corp is a medical technology company engaged in the development, manufacturing, and sales of PET and PET-CT molecular imaging systems for nuclear medicine providers across North America. Its solutions improve patient outcomes while offering cost-effective diagnostics. Its Attrius PET and NeuSight PET-CT systems provide imaging for cardiac diagnostics, with upcoming innovations like the Affinity PET-CT 4D 64 Slice extending its capabilities to both cardiac and oncology imaging. It is focus on providing cost effective solutions, by leveraging strategic partnerships, innovative technology, and flexible business models.

News

POSC

Positron CFO Buys 120M Shares at $0.0025

Positron&#39;s Attrius Receives Health Canada Approval

Positron Corp

POSCO HOLDINGS INC. American Depositary Shares (Each representing 1/4th of a share of Common Stock)

POSCO Holdings Inc

Guidance

UPDATE: Post Sees Financial Impact Of Klingerstown, Lenox Incidents $5-$7M To Adj. EBITDA In Q3

Positron Corporation (OTCBB: <a class="ticker" href="/stock/posc#OTCBB">POSC</a>), is pleased to announce today that on December 12, 2011, the 
Company's Positron Emission Tomography Scanner(s) Attrius &amp; Attrius L have 
received approval for sale in Canada.
The Medical Device License from Health Canada was granted to the Attrius 
systems manufacturer, Neusoft Positron Medical Systems. NPMS is a joint 
venture between Neusoft Medical Systems of Shenyang, China and Positron 
Corporation. Positron Corporation has exclusive rights to sell Attrius in 
North America.

Positron's Attrius Receives Health Canada Approval

Press Releases

Positron Corporation Announces Attrius® PET System Sale

General

Positron Corporation Orders 5 NeuSight PET-CT Scanners for US Market

Positron Corporation Introduces New, Advanced Designed, Economically Priced PET-CT

Positron Corporation Announces Sale of NeuSight PET-CT Scanner

Positron Corporation Launches Prime Rental Program for Pet-Ct Systems

Positron Corporation Partners With Upbeat Cardiology Solutions to Expand Cardiac PET-CT Offerings

Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach

Actineer Appoints Radiopharmaceutical Executive Joseph Oliverio as President and CEO

Positron Corporation Secures Agreement to Sell and Rent Eight NeuSight PET-CT Scanners

Positron Corporation Announces Sale of Attrius PET and NeuSight PET-CT Scanners

Positron

Positron Corporation (OTCBB: <a class="ticker" href="/stock/posc#OTCBB">POSC</a>), is pleased to announce today that on December 12, 2011, the
Company's Positron Emission Tomography Scanner(s) Attrius & Attrius L have
received approval for sale in Canada.

The Medical Device License from Health Canada was granted to the Attrius
systems manufacturer, Neusoft Positron Medical Systems. NPMS is a joint
venture between Neusoft Medical Systems of Shenyang, China and Positron
Corporation. Positron Corporation has exclusive rights to sell Attrius in
North America.

Comments

Positron

News

Latest news for Positron (OTC:POSC) Stock

Friday, June 15, 2018

Wednesday, May 28, 2014

Wednesday, December 14, 2011

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga